DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Metolazone (Metolazone) - Disease Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Disease Progression (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Metolazone where reactions include disease progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Metolazone side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-08

Patient: male, weighing 114.6 kg (252.1 pounds)

Reactions: Blood Creatinine Increased, Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide
    Dosage: 120 mg, tid
    Administration route: Oral
    Start date: 2011-12-26
    End date: 2012-03-29

Blinded Aliskiren
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Bumetanide
    Dosage: 8 mg, unk
    Start date: 2011-12-03
    End date: 2011-12-13

Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Furosemide
    Dosage: unk
    Start date: 2011-12-13

Metolazone
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-05
    End date: 2011-12-08

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Bumetanide
    Dosage: 2 mg x 4
    Start date: 2011-12-03
    End date: 2011-12-13

Furosemide
    Dosage: 120 + 80 + 120 mg
    Start date: 2011-12-14
    End date: 2011-12-20

Blinded Aliskiren
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Other drugs received by patient: Spironolactone; Metoprolol; Hydrochlorothiazde TAB; Warfarin Sodium; Spironolactone; Spironolactone; Digoxin; Digoxin; Simvastatin



Possible Metolazone side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-24

Patient: male, weighing 114.6 kg (252.1 pounds)

Reactions: Blood Creatinine Increased, Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aliskiren
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Metolazone
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-05
    End date: 2011-12-08

Blinded Aliskiren
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Furosemide
    Dosage: 120 mg, tid
    Administration route: Oral
    Start date: 2011-12-26
    End date: 2012-03-29

Bumetanide
    Dosage: 8 mg, unk
    Start date: 2011-12-03
    End date: 2011-12-13

Furosemide
    Dosage: unk
    Start date: 2011-12-13

Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Start date: 2011-12-21

Furosemide
    Dosage: 120 + 80 + 120 mg
    Start date: 2011-12-14
    End date: 2011-12-20

Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-07-08
    End date: 2011-11-30

Other drugs received by patient: Hydrochlorothiazide; Spironolactone; Digoxin; Digoxin; Simvastatin; Warfarin Sodium; Metoprolol Tartrate



Possible Metolazone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Cardiac Failure Chronic, Coronary Artery Disease, Concomitant Disease Progression, Hypokalaemia, Disease Progression, Ventricular Tachycardia, Hypomagnesaemia, Thrombocytopenia, Hepatic Cirrhosis, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Metolazone
    Dosage: 5 mg, every 10 days
    Indication: Cardiac Failure Congestive
    Start date: 2011-10-07

Furosemide
    Dosage: 80 mg qam and 40 mg qpm
    Indication: Cardiac Failure Congestive
    Start date: 2006-01-01

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Valsartan
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Other drugs received by patient: Aspirin; Carvedilol; Micardis; Niaspan; Crestor; Micardis



Possible Metolazone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23

Patient: male, weighing 108.8 kg (239.4 pounds)

Reactions: Cardiac Failure Chronic, Ventricular Tachycardia, Hypomagnesaemia, Coronary Artery Disease, Concomitant Disease Progression, Hypokalaemia, Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide
    Dosage: 80 mg qam and 40 mg qpm
    Indication: Cardiac Failure Congestive
    Start date: 2006-01-01

Metolazone
    Dosage: 5 mg every 10 drop
    Indication: Cardiac Failure Congestive
    Start date: 2011-10-07

Enalapril Maleate
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Potassium Supplements

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Valsartan
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2011-05-01

Other drugs received by patient: Crestor; Micardis; Niaspan; Micardis; Carvedilol; Aspirin



Possible Metolazone side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-05

Patient: 52 year old female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Concomitant Disease Progression, Disease Progression, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-07-13
    End date: 2011-07-14

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-05-12
    End date: 2011-07-12

Metolazone



Possible Metolazone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-25

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Renal Failure Acute, Disease Progression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-07-13
    End date: 2011-07-15

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-05-11
    End date: 2011-07-05

Metolazone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-07-02

Other drugs received by patient: Tracleer; Spironolactone; Remodulin; Revatio; Furosemide



Possible Metolazone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-25

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Renal Failure Acute, Disease Progression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-05-11
    End date: 2011-07-05

Imatinib Mesylate
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-07-13
    End date: 2011-07-15

Metolazone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-07-02

Other drugs received by patient: Tracleer; Revatio; Furosemide; Remodulin; Spironolactone



Possible Metolazone side effects in female

Reported by a physician from United States on 2011-10-07

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Disease Progression, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Metolazone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-07-02

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-05-12
    End date: 2011-07-14

Electrolyte Solutions

Other drugs received by patient: Tracleer; Revatio; Furosemide; Remodulin; Spironolactone



Possible Metolazone side effects in female

Reported by a physician from United States on 2011-10-07

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Disease Progression, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Electrolyte Solutions

Metolazone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-07-02

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-05-12
    End date: 2011-07-14

Other drugs received by patient: Tracleer; Remodulin; Spironolactone; Revatio; Furosemide



Possible Metolazone side effects in 52 year old female

Reported by a physician from United States on 2011-10-03

Patient: 52 year old female, weighing 52.0 kg (114.4 pounds)

Reactions: Cardiac Failure, Concomitant Disease Progression, Disease Progression, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-05-11
    End date: 2011-07-13

Metolazone

Imatinib Mesylate
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-07-13
    End date: 2011-07-15

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017